Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C15H21N5O4 |
Molecular Weight | 335.3583 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=NC3=C2N=CN=C3NC4CCCC4
InChI
InChIKey=SQMWSBKSHWARHU-SDBHATRESA-N
InChI=1S/C15H21N5O4/c21-5-9-11(22)12(23)15(24-9)20-7-18-10-13(16-6-17-14(10)20)19-8-3-1-2-4-8/h6-9,11-12,15,21-23H,1-5H2,(H,16,17,19)/t9-,11-,12-,15-/m1/s1
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL226 Sources: https://www.ncbi.nlm.nih.gov/pubmed/10841798 |
6.3 nM [EC50] |
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
657378
Created by
admin on Sat Dec 16 11:07:07 GMT 2023 , Edited by admin on Sat Dec 16 11:07:07 GMT 2023
|
PRIMARY | |||
|
41552-82-3
Created by
admin on Sat Dec 16 11:07:07 GMT 2023 , Edited by admin on Sat Dec 16 11:07:07 GMT 2023
|
PRIMARY | |||
|
N6-Cyclopentyladenosine
Created by
admin on Sat Dec 16 11:07:07 GMT 2023 , Edited by admin on Sat Dec 16 11:07:07 GMT 2023
|
PRIMARY | |||
|
7LG47VG1ID
Created by
admin on Sat Dec 16 11:07:07 GMT 2023 , Edited by admin on Sat Dec 16 11:07:07 GMT 2023
|
PRIMARY | |||
|
DTXSID80961807
Created by
admin on Sat Dec 16 11:07:07 GMT 2023 , Edited by admin on Sat Dec 16 11:07:07 GMT 2023
|
PRIMARY |
ACTIVE MOIETY